content_top
34 companies, 1 interpreter! Insight, foresight
and recommendation
and recommendation
Mesoblast Limited (MESO)
-0.27
(-27.00%)
content_middle
Mesoblast Limited (MESO) develops cell-based medicines.
MESO has leveraged its proprietary technology platform based on mesenchymal lineage adult stem cells to establish a portfolio of late-stage product candidates. Its allogeneic cell product candidates target advanced stages of diseases with high and unmet medical needs, including cardiovascular conditions, immunologic and inflammatory conditions, orthopedic disorders, and oncology and hematology conditions.
MESO’s products under the Phase III clinical trials include MPC-150-IM for chronic and end-stage heart failure; MPC-06-ID for chronic low back pain; and MSC-100-IV for acute graft versus host disease in children. It is also developing MPC-300-IV that is in Phase II clinical trials for the treatment of biologic refractory rheumatoid arthritis, and diabetic kidney diseases and type 2 diabetes.
MESO has a collaboration agreement with JCR Pharmaceuticals Co., Ltd. It has operations in the United States, Australia, Singapore, and Switzerland. Mesoblast Limited was founded in 2004 and is headquartered in Melbourne, Australia.
Previous Close:
10.95
Open:
5.88
Bid:
5.71
Ask:
5.84
1yr Target Price:
13.29
Day's Range:
5.72 - 5.95
52wk Range:
0.88 - 3.37
Volume:
34624
Average Daily Volume:
25933
Market Capitalization:
0.00M
Trailing Annual Dividend Yield:
N/A
Shares Outstanding:
0.00M
content_right
- December 3, 2024 - 4:32pm | Out and About, Research Notes, Out and About, Earnings, Earnings Q3
- February 20, 2024 - 11:49am | Out and About, Research Notes, Out and About, Earnings Alert, Earnings, Earnings Q3
- January 18, 2024 - 8:57pm | Out and About, Research Notes, Out and About
- May 27, 2023 - 12:37pm | Out and About, Research Notes, Out and About, Earnings Alert, Earnings, Earnings Q1
- April 10, 2023 - 4:40pm | Out and About, Research Notes, Out and About, Earnings, Earnings Q4
- September 23, 2021 - 7:10pm | Out and About, Research Notes, Out and About, Earnings Q2
- May 30, 2020 - 9:44am | Out and About, Research Notes, Out and About, Earnings Q1
- May 26, 2020 - 8:33am | Research Notes
- May 13, 2020 - 8:59am | Research Notes, Financings
- April 11, 2020 - 1:23pm | Out and About, Research Notes, Out and About, Earnings, Earnings Q4
- September 11, 2018 - 1:18pm | Out and About, Research Notes, Out and About, Earnings, Earnings Q2
- July 2, 2018 - 10:26am | Out and About, Research Notes, Out and About
- June 2, 2018 - 7:11am | Out and About, Out and About, Earnings, Earnings Q1
- March 10, 2018 - 9:22am | Earnings, Earnings Q4
- March 4, 2018 - 11:11am | Analysis, Out and About
- April 4, 2017 - 11:33am | Research Notes
- March 27, 2017 - 12:52pm | Out and About, Research Notes
- March 27, 2017 - 9:25am | Research Notes, Financings
- October 6, 2016 - 7:19am | Research Notes
- August 17, 2016 - 9:55am | Research Notes